Sectors
ALDX
Aldeyra Therapeutics, Inc.
1.49
2 x 1.12
2 x 1.92
bid
ask
+
0.00
0.34%
10:27 AM
timesize
| Ytd | -71.24% | |
| 1y | -74.49% |
1.47
day range
1.51
1.07
52 week range
5.93
| Open | 1.50 | Prev Close | 1.49 | Low | 1.47 | High | 1.51 | Mkt Cap | 89.89M |
| Vol | 187.80K | Avg Vol | 1.31M | EPS | -0.38 | P/E | N/A | Forward P/E | -7.80 |
| Beta | 1.21 | Short Ratio | 6.19 | Inst. Own | 62.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 1.75 | 200-d Avg | 3.11 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 5.85M | ||
| Research and Development Expense | 3.48M | ||
| Selling, General and Administrative Expense | 2.37M | ||
| Operating Income | -5.85M | ||
| Interest Expense | 23.00 | ||
| Net Income | -5.45M | ||
| Net Income Common Stock | -5.45M | ||
| Net Income Common Stock (USD) | -5.45M | ||
| Consolidated Income | -5.45M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -5.45M | ||
| Earning Before Interest & Taxes (USD) | -5.45M | ||
| Weighted Average Shares | 60.32M | ||
| Weighted Average Shares Diluted | 60.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 45.09M | ||
| Cash and Equivalents (USD) | 45.09M | ||
| Current Assets | 47.38M | ||
| Property, Plant & Equipment Net | 161.65K | ||
| Total Assets | 47.54M | ||
| Debt Current | 143.45K | ||
| Total Debt | 143.45K | ||
| Current Liabilities | 9.66M | ||
| Total Liabilities | 9.66M | ||
| Accumulated Retained Earnings (Deficit) | -492.86M | ||
| Shareholders Equity | 37.89M | ||
| Shareholders Equity (USD) | 37.89M | ||
| Assets Non-Current | 161.65K | ||
| Total Debt (USD) | 143.45K | ||
| Deferred Revenue | 6.00M | ||
| Trade and Non-Trade Payables | 137.48K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 70.71K | ||
| Net Cash Flow from Financing | -15.30M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.91M | ||
| Capital Expenditure | -23.10K | ||
| Issuance (Repayment) of Debt Securities | -15.30M | ||
| Net Cash Flow from Investing | -23.10K | ||
| Net Cash Flow from Operations | -4.59M | ||
| Share Based Compensation | 1.64M | ||